Archive for the ‘Treatment’ Category

Live Bb Found – Months After Doxy

https://www.news-medical.net/news/20171214/Study-Living-Lyme-disease-bacteria-found-months-after-antibiotic-treatment.aspx

Study: Living Lyme disease bacteria found months after antibiotic treatment

Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced results of two papers published in the peer-reviewed journals PLOS ONE http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0189071 and American Journal of Pathology, that seem to support claims of lingering symptoms reported by many patients who have already received antibiotic treatment for the disease.

Based on a single, extensive study of Lyme disease designed by Tulane University researchers, the study employed multiple methods to evaluate the presence of Borrelia burgdorferi spirochetes, the bacteria that cause Lyme disease, before and after antibiotic treatment in primates. The study also measured the antibody immune response to the bacteria both pre- and post- treatment, as this is how current diagnostics typically evaluate Lyme disease in humans.

The data show that living B. burgdorferi spirochetes were found in ticks that fed upon the primates and in multiple organs after treatment with 28 days of oral doxycycline. The results also indicated that the immune response to the bacteria varied widely in both treated and untreated subjects.

“It is apparent from these data that B. burgdorferi bacteria, which have had time to adapt to their host, have the ability to escape immune recognition, tolerate the antibiotic doxycycline and invade vital organs such as the brain and heart,” said lead author Monica Embers, PhD, assistant professor of microbiology and immunology at Tulane University School of Medicine.

“In this study, we were able to observe the existence of microscopic disease and low numbers of bacteria, which would be difficult to ‘see’ in humans but could possibly be the cause of the variable and nonspecific symptoms that are characteristic of post-treatment Lyme disease syndrome. Although current antibiotic regimens may cure most patients who are treated early, if the infection is allowed to progress, the 28-day treatment may be insufficient, based on these findings,” Embers said.

The findings also demonstrated:

  • All subjects treated with antibiotics were found to have some level of infection 7 – 12 months post treatment.
  • Despite testing negative by antibody tests for Lyme disease, two of 10 subjects were still infected with Lyme bacteria in heart and bladder.
  • Lyme bacteria which persist are still viable.

To better elucidate previous animal studies demonstrating that some B. burgdorferi bacteria survive antibiotics, the study explored Lyme disease infection in rhesus macaque primates treated with antibiotics and a control group who were also infected but not treated. This species has been shown to demonstrate a progression of Lyme disease most similar to humans, particularly related to erythema migrans, carditis, arthritis, and neuropathy of the peripheral and central nervous systems.

“Clearly, some medical practices governing diagnosis and treatment of Lyme disease should be reconsidered in light of this study. This study shows that we must reevaluate the current paradigm of antibody response tests for diagnosis and move away from the one size fits all approach to Lyme treatment,” said

In the study, ticks carrying B. burgdorferi spirochetes fed on ten primates. Four months post infection, half of the primates (five) received the antibiotic doxycycline orally for 28 days at a proportional dose to that used in human treatment. Five subjects were treated with placebo and all ten were evaluated by more than five different diagnostic methods to characterize any remaining infection. The researchers used several important techniques, including xenodiagnoses, to determine if the spirochete bacteria persisted.

The results show:

  • Few subjects displayed a rash. Although all subjects were infected, only one of the 10 displayed a rash with central clearing, the classical “bulls-eye” rash. The subject that developed this rash, interestingly, never mounted an immune response to five borrelia antigens throughout the study period, prior to and following treatment.
  • Organs may be infected even if antibody tests are negative. One subject which tested negative for B. burgdorferi by skin biopsy cultures, PCR and in vivo cultures, was found to have B. burgdorferi infecting the heart. Another untreated subject, who was ultimately shown to have residual Lyme bacteria in the bladder, showed a decrease in immune response over the course of infection, with a negative xenodiagnosis test in the late stage, which would signal that the animal self-cured.
  • Intact spirochetes were found in three of five treated and four of five untreated subjects based on xenodiagnosis results 12 months after the tick bite.
  • Immune responses to B. burgdorferi varied greatly post-treatment, with one subject’s antibody levels dropping to pre-bite levels for three antigens while another subject experienced elevated antibodies for the same antigens throughout the study period. This is significant because it demonstrates that subjects infected with the same strain of B. burgdorferi may have different immune responses to the same antigen. And, because humans, like primates, are genetically diverse, it underscores that testing antibody responses may be inherently unreliable as a singular diagnostic modality for Lyme disease.
  • Widespread and variable microscopic disease was observed in all infected subjects, despite antibiotic treatment. Compared to uninfected subjects of the same age, infected subjects in this study (treated and untreated) demonstrated Inflammation in and around the heart, in skeletal muscles, joints, and the protective sheath that covers the brain, and near peripheral nerves.
  • Rare, but intact B. burgdorferi spirochetes were found in the tissues of both the treated and untreated subjects. In two subjects treated with doxycycline, multiple Lyme bacteria were observed in the brain tissue. Others organs in which the spirochetes were observed included the heart, joints, bladder, skeletal muscle and adjacent to peripheral nerves.
    Source:
    http://tulane.edu/

_____________

For more:  https://madisonarealymesupportgroup.com/2017/11/03/lyme-bug-stronger-than-antibiotics-in-animals-and-test-tubes-now-study-people/

https://madisonarealymesupportgroup.com/2015/09/19/proof-of-borrelia-persistence/

https://madisonarealymesupportgroup.com/2017/08/18/drexel-prof-lyme-persists/

https://madisonarealymesupportgroup.com/2017/12/02/scottish-doctor-gives-insight-on-lyme-msids/   “If you look at major medical microbiology and infectious disease textbooks, they state that after 4 weeks you can’t find the Lyme bacteria anymore. Therefore Lyme is then categorised as ‘post infectious’. But I get back to the point I’ve made before: if you can’t culture it, you cannot know anything about its viability. You do not have a organism specific test (culture or PCR), that guides your ‘test of cure’. How do you say that a bacteria is killed, when you couldn’t grow and measure it in the first place?”  “One of the rules of infectious diseases medicine is that once you stop treatment and the patient stays better, they are cured. When they get worse, the infection has returned and they have relapse of infection and need repeat treatment. My ID colleagues live by that rule with most other infections, but not with Lyme.”

 

 

 

LDo’s Top 10 Lyme Research Questions

https://www.lymedisease.org/top-ten-lyme-priorities/

Top-Ten-Research-Questions-with-MLD-logo-1024x625

Press release:

LymeDisease.org releases “Top 10 Lyme Disease Research Questions,” as federal government weighs options in fight against growing epidemic.

 

 

Bitter Pill to Swallow for C. diff

https://articles.mercola.com/sites/articles/archive/2017/12/11/poop-pills-can-combat-clostridium-difficile.aspx?  by Dr. Mercola, December 11, 2017

Poop Pills Can Combat Deadly Infections

poop pills

Story at-a-glance

  • An answer to a serious infection called Clostridium difficile (C. diff.) infection comes from a relatively new therapy called fecal microbiota transplantation (FMT)
  • C. diff., a common bacterium in hospitals, is a leading cause of diarrhea in health care today, with older people on medication at greatest risk, and often occurs soon after administration of antibiotics
  • FMT is when feces are transferred from a healthy donor to the gastrointestinal tract of a C. diff-infected patient to reintroduce healthy bacteria into their gut, but the pill form offers a noninvasive alternative
  • In terms of patient comfort, fewer trial subjects who were given the FMT capsule described the experience as “unpleasant” compared to receiving FMT through the colonoscopy route
  • Your gut health, as well as your overall health, are closely interconnected, so “feeding” your microbiome, as well as resisting antibiotics as much as possible, will optimize your microbiome

While it would seem that a fecal transplant in capsule form would be a somewhat bitter pill to swallow, scientists conducting a randomized clinical trial1 found this mode of transportation, in a matter of speaking, for fecal therapy was easier and just as effective for treating patients infected with the serious and dreaded Clostridium difficile infection (RCDI), or simply “C. diff.,” as receiving a fecal transplant via enema or colonoscopy, also known as fecal microbiota transplantation (FMT).

Further, FMT in pill form has the capacity to improve patients’ quality of life, as it caused fewer adverse events.2 For those who may be unaware of this protocol, fecal transplants are now not just common, but according to one study, so successful that the first trial was stopped early because the researchers deemed it unethical to withhold the treatment from patients (as some typically are given alternative therapies). As noted by NPR:

“That’s because C. diff. is kind of a special case. It’s a very invasive microbe that has repeatedly been assaulted by antibiotics which have caused a collapse in other microbes. So it’s an easy environment for microbes in a donor stool to invade.”3

C. Diff.:  Common Bacterium in Hospital Environments

One of the problems with C. difficile is that it’s one of the most common health care-associated infections and one of the foremost reasons hospital patients develop debilitating, recurrent diarrhea that’s hard to get a handle on, medically. It’s especially rampant among older individuals on antibiotics for other conditions. CIDRAP states:

“(C. diff.) can also be difficult to completely cure. As a result, recurrent infections have become a growing challenge. At least 20 percent of patients who get an initial CDI have a recurrent infection within eight weeks, with the risk of RCDI being as high as 50 percent to 60 percent after three or more infections.”4

Researchers at Brown University, where one program focuses on digestive microbes such as bacteria, fungi and viruses (human microbiomes), say C. diff. became hard to manage when antibiotics prescribed for other conditions disturbed what may have been perfectly functioning, benign gut organisms. By no means a trifling infection, Newsweek pulls no punches as it calls C. diff. both “nasty” and “deadly.”

Antibiotics may be the usual treatment in hospitals, but they only contribute to the problem by effectively wiping out beneficial bacteria in patients’ collective microbiome that might keep C. diff. in check, CIDRAP observes. In essence, FMT can be explained as feces being transferred from one healthy donor to the gastrointestinal tract of a C. diff. infected patient. The purpose is to “reintroduce healthy bacteria into the gut (as) a non-antibiotic therapy that’s shown promise in clinical studies.”5

What Happens When Your Gut Biome Becomes This Compromised?

C. diff. infection impacts half a million people in the U.S. every year. Further, it’s fatal for 15,000 of them, also every year, according to the Centers for Disease Control and Prevention (CDC).6 Still, there have been patients who found the prospect of fecal transplant therapy, even through surgical means, to be just too daunting. In fact, efforts have actually been made to extract the beneficial bacteria from the fecal matter to make the idea of swallowing it more palatable, but the effort failed.

Far from being a brand-new, innovative idea, using poop to fight the effects of C. diff. and other problems in patients has been around since at least the late 1950s. Different names, besides FMT, have included fecal biotherapy and fecal flora reconstitution. One study explains the science behind it:

“FMT involves reconstituting the normal intestinal microflora in a diseased person by infusion (via nasogastric tube, enema or colonoscopy) of a liquid suspension of stool from a healthy donor. The first report of the use of FMT (for a patient with non-CDI pseudomembranous colitis) was published in 1958. Since then, there has been mounting evidence supporting its use in recurrent CDI.”7

Your Microbiome Can Make or Break Your Health

How your microbiome works is still being scrutinized by scientists, especially in the way it can make or break your overall health. It’s clear that certain foods are considered positive for “feeding” your microbiome. Foods containing fiber are at the top of the list as they release nutrients for your gut lining. The connection between what you eat and how healthy your gut is are closely interconnected, so consider adding more fiber, especially if you aren’t getting the 50 grams of fiber per 1,000 calories you eat that I recommend.

One way fiber benefits your health is by providing beneficial bacteria in your gut with the materials needed to thrive. These beneficial bacteriaassist with digestion and absorption of your food, and play a significant role in your immune function.

One of the best ways to regain optimal balance in your gut is by eating fermented foods. Besides kimchi and other fermented vegetables, which you can make at home very easily, there are also fermented beverages such as kefir and yogurt, all providing trillions of beneficial bacteria — far more than you can get from a probiotics supplement.

Poop Pills, a Colonoscopy or the Other Alternatives?

It’s been a tough call for scientists and physicians alike, trying to determine which is worse: C. diff., antibiotics, colonoscopies (the most successful in terms of introducing fecal matter into patients) or the new poop pill-popping protocol. C. diff. being what it is comes with serious, life-altering symptoms, which Medline Plus8 says can include:

Watery diarrhea multiple times daily Stomach cramps Fever
Dehydration Nausea Abdominal pain and tenderness

A colonoscopy is an example of an invasive procedure, but there’s also the fact that patients typically undergo mild sedation, which introduces another risk because their breathing may become too slow. Further, there’s the chance that in the course of the procedure, the patient’s intestinal wall could be punctured, which could introduce life-threatening infections. Time observed:

“The benefits of swallowing a capsule are also undeniable compared to swallowing — or trying to swallow — a feeding tube through which a slurry of fecal matter is flowing through. (That’s the way that doctors testing fecal transplants originally administered their doses.) That carries the risk of aspirating some of the fecal slurry into the lungs — not to mention the unpleasantness of introducing feces to the mouth area and accidentally breathing it in.”9

The Poop-in-a-Capsule Trial

Dina Kao, a gastroenterologist at the University of Alberta in Canada, used the pills described by Time10 as “fecal matter manufactured into a capsule” for 116 patients in the trial. Compared to a colonoscopy, both methods showed a 90 percent reduction in C. diff. relapses. All 116 study subjects had suffered a minimum of three bouts of C. diff. and were randomly assigned a poop swap via either the capsule or colonoscopy.

It must have been an exercise in “mind over matter” for the patients who were required to swallow down 40 capsules in one sitting, which took an average of a half-hour to an hour. The reduction in C. diff. relapse was determined after 90 percent of the patients remained C. diff.-free after 12 weeks. Preeti Malani, professor of medicine at the University of Michigan, who wrote an editorial to go with the study, noted:

“Based on this study, I think it would be very reasonable to think about fecal transplant capsules as your preferred approach. If it were myself or a family member, I think avoiding colonoscopy would be helpful.”

Still, Melani and other researchers believe more studies are needed, not only to confirm the results found in Kao’s study, but also to get a better understanding of how fecal transplant works.

Kao herself says she plans to study all the components of fecal transplants to get a clearer picture of what exactly helps control C. diff. Besides C. diff., microbe transplanting via a capsule is also a therapy currently used for obesity, diabetes, colitis and Crohn’s disease. It’s a way gut bacteria can be positively linked to lowering the risks of such disorders and conditions as obesity, allergies, asthma and even some mental illnesses.

A Protocol Still Unapproved by Government Agencies

While fecal transplantation may at first glance come across as quackery of the highest degree, once you understand the process, it’s clear it’s a successful way to swap bad bacteria for good.

Kao, whose first reaction upon the successful trial, quipped, “It’s absolutely insane. We just don’t see (this) kind of efficacy with drugs,”11 added that she believes the favorable outcome of the fecal transplant pills will “transform” the way conventional medicine at large thinks about the unconventional therapy. She listed several of the benefits over the current protocols of antibiotics or surgery. Poop pills are:

  • Noninvasive
  • Less expensive
  • Free of the risks associated with sedation
  • Can be done in a doctor’s office

As it stands, the Food and Drug Administration (FDA) hasn’t yet given the proverbial green light to fecal transplants.It does, however, permit doctors to perform the therapy for patients not currently responding favorably to other forms of remediation, but only as long as patients understand that the poop pill is still being scrutinized as a viable treatment.

In addition, CIDRAP notes that in March 2016, the FDA proposed regulations that would further restrict use of FMT by requiring that either the patient recipient or the treating clinician personally know the donor — a restriction that, as yet, is not finalized.

Interestingly, among patients who’ve been asked what they thought of the idea of swallowing poop pills, most responded that after all was said and done, it wasn’t too bad. Newsweek observes that two-thirds of the 57 patients who got the pills described the experience as “not at all unpleasant,” while 44 percent of the 59 patients who underwent FMT via a colonoscopy were not as positive.

Perhaps when the patients remembered the alternative — that to them, poop pills were a hero of sorts due to their ability to stop the unstoppable on the other end — the therapy could only be seen in a positive light. As Kao concluded, “We still don’t understand what’s going on, and in these other conditions it’s not as clear-cut that the disturbance in the bacterial composition is the cause. Stool is such a complex mixture.”12

– Sources and References

_______________

**Comment**

Lyme/MSIDS patients use antimicrobials and have to be concerned with gut health.  In fact, antibiotic resistance and adverse events are often cited by some physicians as to why they shouldn’t be used or only in extremely limited amounts.  FMT is a clear and concise answer for this potential problem, and I pray people are taking note.  

Any treatment demands a risk/benefit assessment and until the denialists understand the severity/complexity of Lyme/MSIDS, patients will be swimming against the current and having to fight for proper/effective treatment which is much more than 21 days of doxy.  Doxy, for instance, will not touch numerous coinfections and has been found to throw the spirochete into the non-cell wall form to rear its ugly head later.  https://madisonarealymesupportgroup.com/2017/11/03/lyme-bug-stronger-than-antibiotics-in-animals-and-test-tubes-now-study-people/

https://madisonarealymesupportgroup.com/2016/02/13/lyme-disease-treatment/

https://madisonarealymesupportgroup.com/2016/01/16/babesia-treatment/

https://madisonarealymesupportgroup.com/2016/01/03/bartonella-treatment/

 

https://madisonarealymesupportgroup.com/2016/02/07/mycoplasma-treatment/

Ozone Ten Pass – Lyme/MSIDS Treatment in CA

http://lymebook.com/bryan/2017/12/03/new-lyme-treatment-is-mainstay-for-southern-california-llmd/

New Lyme treatment is mainstay for Southern California LLMD

CA DoctorDr. Mary Ellen Shannon, M.D., of Center for New Medicine, Irvine, CA. In this photo, she administers a new Lyme treatment called “ozone ten pass.”

 

Summary: This article will profile a new Lyme treatment, and one of the world’s leading physicians using the therapy. I’ve personally been treated by Dr. Mary Ellen Shannon, and I highly recommend her. You can contact her through her clinic, Center for New Medicine (Irvine, CA). She is an LLMD (Lyme Literate Medical Doctor).

When I wrote my first Lyme disease book, Lyme Disease and Rife Machines, I discussed the benefits of ozone therapy. Ozone therapy is incredible for many reasons. Until now, however, I believe that ozone therapy has been limited because there are no superb ways to get enough ozone into the body.

Don’t get me wrong – many of the ways in which ozone has been administered for the past several decades are good. They do work, and are useful. But they haven’t been life-changing or ground-breaking for many patients.

That is, until now. A new method of administering ozone, called “ozone ten pass”, has been a game-changer for many Lyme disease patients. Let me explain what this is.

Before ozone ten pass, the most powerful method of ozone administration was called MAH, which stands for Major Autohemotherapy. In simple terms, this is a procedure where a small amount of a patient’s blood is taken out of his or her body, and exposed to ozone, and then returned to the body. This practice has been performed for decades, especially in Russia and other countries where innovation is common in ozone therapy.

MAH has helped many Lyme patients, no doubt. But still, it wasn’t really game-changing for the vast majority.

This is why ozone ten pass is so exciting. A very smart researcher and leader in the field of ozone, Dr. Johann Lahodney, developed ozone ten pass as a way to get more ozone into the body. Essentially, ozone ten pass involves doing ten MAH treatments – all in one sitting! Blood is taken out, ozonated, and put back in the body, ten times, in about an hour.

Several years ago, ozone ten pass was new, and wasn’t widely available. However, as it has become more evident that it can be game-changing for not just Lyme disease but also many other conditions, more and more American physicians have begun to incorporate it into their practices. So it is a very good time to look into ozone ten pass, because it is much more available than it has ever been before. And furthermore, the training that doctors receive is more advanced than ever.

One unique characteristic of ozone ten pass is that each subsequent pass in the treatment can help to neutralize toxins and clean up the mess left by previous passes. And this all happens in one sitting – one treatment. This doesn’t mean that patients don’t herx with ten pass – some of them do. But, the ten pass process introduces some new and intriguing variables and benefits compared to MAH alone. (Disclaimer: Don’t forget to work closely with your doctor to determine if you should start at a full ten passes, or start at a lower amount – the treatment is very powerful and should be treated with great respect).

After researching ozone ten pass for Lyme disease, I’ve come to the conclusion that it is a BIG step forward in Lyme disease treatment. In fact, I personally have traveled to see Dr. Shannon twice. As I write this, I am in Oceanside, CA, where I am having consultation with her.

Some Lyme disease patients report having dramatic results after their first few treatments (remember, each “treatment” consists of up to ten “passes” of ozone. So when I say “one treatment,” I mean one full ten pass). More and more anecdotal evidence is popping up all over the internet.

One physician has an entire YouTube channel devoted to testimonials of patients using ozone. Many of these patients are Lyme disease patients. I enjoyed watching his videos and hearing the many stories as I made my own preparations to undergo ozone therapy with Dr. Shannon.

Also, I suggest you do a google search for “ozone ten pass Lyme disease” and read about many of the people who’ve been using this treatment. There are YouTube videos, blogs, Facebook groups, and other resources available.

Of course, ozone ten pass does require a doctor to perform, so you’ll need to find a doctor offering ozone ten pass, or travel to go see one like I did.

 

The Zottzman ozone device used to administer treatment

Which brings me to the doctor who I am profiling in this article: Dr. Mary Ellen Shannon, MD, of the Center for New Medicine, in Irvine, CA. Dr. Shannon has more experience administering this therapy than almost any other physician in the United States. In fact, she has administered this therapy on herself dozens of times, to cure herself of a serious life-threatening illness. I highly recommend watching her present on ozone and tell her story here. Even while ozone ten pass was new, and many physicians were very inexperienced, Dr. Shannon was using the therapy on herself daily, to regain her health. Hence, her experience, competency, and wisdom far surpass any other ozone doctor I’ve met or even heard of, with the exception of the inventor himself.

If you are considering ozone ten pass, I highly recommend Dr. Shannon, and as mentioned, I personally received treatment from her. I screened a half dozen ozone doctors and chose her because of her extensive experience and personal journey with ozone. Her clinic is equipped with near-endless state-of-the-art advanced, integrative treatment tools (Dr. Shannon jokes that her clinic is the “Disneyland” of alternative medicine!). She is also a very warm, caring, empathetic individual, and she thinks outside the box in addressing Lyme and related conditions. She has extensive experience treating many neuro-degenerative conditions, as well as cancer. Every time I see her, she is telling me about a new cutting edge Lyme disease therapy she is using in her clinic. Likewise, she is very open-minded and willing to hear you out on whatever you have to say about your own unique healing challenges and any new treatments you are considering. As an ozone doctor and an LLMD, she is fantastic.

Though it may be difficult for some people to travel all the way to Southern California to see her, I found that my own journey to this doctor was highly worthwhile. I’ve also found that ozone ten pass has played a huge role in my ongoing recovery.

Feel free to leave a comment below with thoughts or questions. You can contact Dr. Shannon at 949.680.1880 or through the clinic website.

______________

**Comment**

I’ve personally used MAH (where a pint of blood is taken out and infused with ozone) weekly for two and a half months as well as having the oxygenated blood run through infared light.  To be honest, for the money and time it takes I wasn’t impressed.  Antibiotics did far more for me for much less money; however, I knew about this ten-pass approach and begged my LLMD to do it as German doctors are using this approach for cancer with good success.  I truly feel it’s dose dependent.  For those of you in CA, this may be a game-changer for you.  Let me know how you progress.  The beauty of it is it will deal with ALL infections – including viruses.

 

Still a Pig With Lipstick: CDC Removes Link to IDSA Guidelines

https://www.lymedisease.org/touchedbylyme-cdc-lipstick-on-pig/  Touched by Lyme
by Dorothy Kupcha Leland, DEC 2017

CDC website removes link to IDSA guidelines. Just lipstick on a pig?

Thanks to Lyme advocates on Facebook this morning for pointing out that the CDC Lyme pages were updated on Dec.1, 2017, with a number of notable changes.

For instance, the agency has REMOVED the link to the Infectious Diseases Society of America’s 2006 Lyme guidelines from its Lyme treatment page. Other references to those guidelines have apparently been disappeared from throughout the website as well.

For anyone new to this issue, the IDSA guidelines have long been like a sharp poke in the eye to the Lyme community. The guidelines define Lyme so narrowly that many people are denied a diagnosis in the first place. If you do manage to get diagnosed under their restrictive criteria, the guidelines allow only very brief treatment.

Insurance companies love the IDSA Lyme guidelines, because they can avoid paying for longer treatment for people with Lyme disease. People suffering with Lyme disease hate them, because the guidelines make it difficult, if not impossible, to get the treatment they need to get well.

So, having the CDC finally remove this link from its website is…interesting.

Here’s a screen shot of the CDC’s Lyme treatment page from Nov. 1, 2017. You can see that odious link in the middle there, shining bright as day.

CDC-screenshot-1024x238

And here’s what the page looks like this morning (Dec. 2, 2017):

cdc-screenshot2

Does this represent a change of heart by the CDC regarding Lyme treatment? Probably not. If you look at the current page, the recommendations for early treatment are in line with IDSA guidelines, without naming them.

And you’ll notice that for information about “chronic Lyme disease” and long-term treatment, the CDC page kicks you to the National Institutes of Health website. If you follow the link, you’ll find the same-old, same-old tripe about how long-term treatment doesn’t help, etc. (Based on three statistically puny studies of “chronic Lyme” the NIH funded years ago.)

Perhaps the CDC is trying to make its ties to the IDSA less glaringly obvious.

What’s the old phrase about putting lipstick on a pig? Still a pig.

In a separate but related development: The primary architect of the 2006 IDSA Lyme guidelines, Dr. Gary Wormser, was recently named to the new federal Tick-Borne Diseases Working Group. LymeDisease.org is protesting his appointment, based on his flagrant financial conflicts of interest with lab companies and other commercial enterprises.

Click here to read more about this issue & sign the petition:  https://www.change.org/p/dr-richard-wolitski-remove-wormser-from-federal-tbd-working-group-due-to-financial-conflicts-of-interest

TOUCHED BY LYME is written by Dorothy Kupcha Leland, LymeDisease.org’s VP for Education and Outreach. She is co-author of When Your Child Has Lyme Disease: A Parent’s Survival Guide. Contact her at dleland@lymedisease.org